Recombinant human erythropoietin (rhEPO) in the prevention and treatment of chemotherapy-induced anaemia
- PMID: 9819790
- DOI: 10.1007/BF02821932
Recombinant human erythropoietin (rhEPO) in the prevention and treatment of chemotherapy-induced anaemia
Comment on
-
Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy.Med Oncol. 1998 Sep;15(3):174-82. doi: 10.1007/BF02821936. Med Oncol. 1998. PMID: 9819794 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical